ํTWST โข NASDAQ
add
ํธ์์คํธ ๋ฐ์ด์ค์ฌ์ด์ธ์ค
์ ์ผ ์ข
๊ฐ
$52.88
์ผ์ผ ๋ณ๋ํญ
$52.48 - $57.25
52์ฃผ ๋ณ๋ํญ
$23.30 - $57.25
์๊ฐ์ด์ก
34.73์ต USD
ํ๊ท ๊ฑฐ๋๋
152.34๋ง
์ฃผ๊ฐ์์ต๋ฅ
-
๋ฐฐ๋น์์ต๋ฅ
-
๊ธฐ๋ณธ ๊ฑฐ๋์
NASDAQ
๋ด์ค
์ฌ๋ฌด
์์ต๊ณ์ฐ์
์์ต
์์ด์ต
| (USD) | 2025๋ 12์info | ์ ๋ ๋๋น ๋ณ๋ |
|---|---|---|
์์ต | 1.04์ต | 16.89% |
์ด์๋น | 8687.20๋ง | 12.12% |
์์ด์ต | -3050.70๋ง | 3.44% |
์์ด์ต๋ฅ | -29.42 | 17.38% |
์ฃผ๋น ์์ต | -0.50 | 5.66% |
EBITDA | -2700.60๋ง | 5.45% |
์ ํจ ์ธ์จ | -0.84% | โ |
๋์ฐจ๋์กฐํ
์ด์์ฐ
์ด๋ถ์ฑ
| (USD) | 2025๋ 12์info | ์ ๋ ๋๋น ๋ณ๋ |
|---|---|---|
ํ๊ธ ๋ฐ ๋จ๊ธฐ ํฌ์ | 1.98์ต | -26.91% |
์ด์์ฐ | 6.38์ต | 4.85% |
์ด๋ถ์ฑ | 1.82์ต | 19.23% |
์ด์๊ธฐ์๋ณธ | 4.56์ต | โ |
๋ฐํ ์ฃผ์ | 6131.17๋ง | โ |
์ฃผ๊ฐ์์์ฐ๋น์จ | 7.11 | โ |
์ด์์ฐ์ด์ต๋ฅ | -12.85% | โ |
์๋ณธ์ด์ต๋ฅ | -14.52% | โ |
ํ๊ธ ํ๋ฆ
์ํ๊ธํ๋ฆ
| (USD) | 2025๋ 12์info | ์ ๋ ๋๋น ๋ณ๋ |
|---|---|---|
์์ด์ต | -3050.70๋ง | 3.44% |
์์
ํ๊ธ ํ๋ฆ | -2481.40๋ง | -15.80% |
ํฌ์ ํ๊ธ ํ๋ฆ | -993.30๋ง | -546.68% |
์๊ธ ์กฐ๋ฌ ํ๊ธ ํ๋ฆ | 29.80๋ง | -98.34% |
์ํ๊ธํ๋ฆ | -3444.00๋ง | -578.89% |
์์ฌ ํ๊ธ ํ๋ฆ | -2585.55๋ง | -130.04% |
์ ๋ณด
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
์ค๋ฆฝ
2013
์น์ฌ์ดํธ
์ง์ ์
979